A detailed history of Iron Triangle Partners LP transactions in Insmed Inc stock. As of the latest transaction made, Iron Triangle Partners LP holds 180,000 shares of INSM stock, worth $13.8 Million. This represents 1.86% of its overall portfolio holdings.

Number of Shares
180,000
Previous 413,196 56.44%
Holding current value
$13.8 Million
Previous $27.7 Million 52.54%
% of portfolio
1.86%
Previous 2.82%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $14.5 Million - $18.4 Million
-233,196 Reduced 56.44%
180,000 $13.1 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $9.09 Million - $28.8 Million
413,196 New
413,196 $27.7 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.4B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Iron Triangle Partners LP Portfolio

Follow Iron Triangle Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Iron Triangle Partners LP with notifications on news.